Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth (Status and Outlook) 2023-2029
ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
LPI (LP Information)' newest research report, the “Enzyme-Linked Immunosorbent Assay (ELISA) Industry Forecast” looks at past sales and reviews total world Enzyme-Linked Immunosorbent Assay (ELISA) sales in 2022, providing a comprehensive analysis by region and market sector of projected Enzyme-Linked Immunosorbent Assay (ELISA) sales for 2023 through 2029. With Enzyme-Linked Immunosorbent Assay (ELISA) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzyme-Linked Immunosorbent Assay (ELISA) industry.
This Insight Report provides a comprehensive analysis of the global Enzyme-Linked Immunosorbent Assay (ELISA) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzyme-Linked Immunosorbent Assay (ELISA) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enzyme-Linked Immunosorbent Assay (ELISA) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzyme-Linked Immunosorbent Assay (ELISA) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzyme-Linked Immunosorbent Assay (ELISA).
The global Enzyme-Linked Immunosorbent Assay (ELISA) market size is projected to grow from US$ 175.1 million in 2022 to US$ 226.3 million in 2029; it is expected to grow at a CAGR of 3.7% from 2023 to 2029.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzyme-Linked Immunosorbent Assay (ELISA) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Segmentation by application
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook